-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 T+itCr6zRklckROTUqjrVrREcVKgha4W8BXLFSg+nd383hKQEfwr2SywmrJP1Bab
 2ri24H/HJ8H0l6I4QoTJvw==

<SEC-DOCUMENT>0001422847-10-000002.txt : 20100222
<SEC-HEADER>0001422847-10-000002.hdr.sgml : 20100222
<ACCEPTANCE-DATETIME>20100222112755
ACCESSION NUMBER:		0001422847-10-000002
CONFORMED SUBMISSION TYPE:	D/A
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20100222
DATE AS OF CHANGE:		20100222
EFFECTIVENESS DATE:		20100222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Drais Pharmaceuticals Inc
		CENTRAL INDEX KEY:			0001422847
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		D/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-112966
		FILM NUMBER:		10621603

	BUSINESS ADDRESS:	
		STREET 1:		23 Overbrook Dr
		CITY:			Princeton
		STATE:			nj
		ZIP:			07401
		BUSINESS PHONE:		201-909-3059

	MAIL ADDRESS:	
		STREET 1:		23 Overbrook Dr
		CITY:			Princeton
		STATE:			nj
		ZIP:			07401
</SEC-HEADER>
<DOCUMENT>
<TYPE>D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0603</schemaVersion>

    <submissionType>D/A</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001422847</cik>
        <entityName>Drais Pharmaceuticals Inc</entityName>
        <issuerAddress>
            <street1>520 US Highway 22, Suite 201</street1>
            <city>Bridgewater</city>
            <stateOrCountry>NJ</stateOrCountry>
            <zipCode>08807</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>908-895-1200</issuerPhoneNumber>
        <jurisdictionOfInc>DELAWARE</jurisdictionOfInc>
        <issuerPreviousNameList>
            <value>None</value>
        </issuerPreviousNameList>
        <edgarPreviousNameList>
            <value>None</value>
        </edgarPreviousNameList>
        <entityType>Corporation</entityType>
        <yearOfInc>
            <withinFiveYears>true</withinFiveYears>
            <value>2007</value>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Donna</firstName>
                <lastName>Tempel</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Drais Pharmaceuticals, Inc.</street1>
                <street2>520 US Highway 22, Suite 201</street2>
                <city>Bridgewater</city>
                <stateOrCountry>NJ</stateOrCountry>
                <zipCode>08807</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Robert</firstName>
                <lastName>Desjardins</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Drais Pharmaceuticals, Inc.</street1>
                <street2>520 US Highway 22, Suite 201</street2>
                <city>Bridgewater</city>
                <stateOrCountry>NJ</stateOrCountry>
                <zipCode>08807</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Arnold</firstName>
                <lastName>Oronsky</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Drais Pharmaceuticals, Inc.</street1>
                <street2>520 US Highway 22, Suite 201</street2>
                <city>Bridgewater</city>
                <stateOrCountry>NJ</stateOrCountry>
                <zipCode>08807</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Jeff</firstName>
                <lastName>Bird</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>c/o Drais Pharmaceuticals, Inc.</street1>
                <street2>520 US Highway 22, Suite 201</street2>
                <city>Bridgewater</city>
                <stateOrCountry>NJ</stateOrCountry>
                <zipCode>08807</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Director</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification></relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Biotechnology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Decline to Disclose</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>true</isAmendment>
                <previousAccessionNumber>9999999997-08-009019</previousAccessionNumber>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2007-12-14</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>true</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isEquityType>true</isEquityType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>0</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>Indefinite</totalOfferingAmount>
            <totalAmountSold>20000000</totalAmountSold>
            <totalRemaining>Indefinite</totalRemaining>
            <clarificationOfResponse></clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>31</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse>The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business.</clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>Drais Pharmaceuticals Inc</issuerName>
                <signatureName>/s/ Donna Tempel</signatureName>
                <nameOfSigner>Donna Tempel</nameOfSigner>
                <signatureTitle>President</signatureTitle>
                <signatureDate>2010-02-18</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----